Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate

J Allergy Clin Immunol Pract. 2022 Aug;10(8):2172-2175.e1. doi: 10.1016/j.jaip.2022.05.035. Epub 2022 Jul 13.

¹ Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Disease, National Institute of Health, Bethesda, Md.
² Division of Allergy and Immunology, Children's National Hospital, Washington, DC; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.
³ Division of Allergy and Immunology, Children's National Hospital, Washington, DC.
⁴ Division of Allergy and Immunology, Children's National Hospital, Washington, DC; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC. Electronic address: joelpbrooks@gmail.com.

No abstract available

Publication types